<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04198740</url>
  </required_header>
  <id_info>
    <org_study_id>CE19.212</org_study_id>
    <nct_id>NCT04198740</nct_id>
  </id_info>
  <brief_title>Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface</brief_title>
  <acronym>EML-MSO</acronym>
  <official_title>Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Université du Québec a Montréal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to obtain the lacrimal fingerprint for frequent pathologies of the ocular
      surface and establish a normative base for each of them.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an exploratory study. The investigators aim to:

        -  Test and perfect a tear sample analysis technique by mass spectrometry with samples
           collected by Schirmer strips;

        -  Obtain the lacrimal fingerprint for various pathologies of the ocular surface, notably
           different forms of dry eye syndrome, infectious keratitis/conjunctivitis, mucous
           membrane pemphigoid and allergic conjunctivitis, and establish a normative base for each
           of them.

      During regular clinics at the cornea service of the ophthalmology department of the CHUM
      (Centre Hospitalier de l'Université de Montréal), the investigators aim to recruit a few
      hundred patients with various pathologies of the ocular surface, notably different forms of
      dry eye syndrome, infectious keratitis/conjunctivitis, mucous membrane pemphigoid and
      allergic conjunctivitis, and collect a sample of their tears via Schirmer strip. A case
      report form will be completed for each patient, noting known ocular diagnoses and active
      topical ophthalmic medication. Schirmer strips will be sent in sterile tubes to UQAM
      (Université du Québec à Montréal)'s department of chemistry for analysis by mass
      spectrometry.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Anticipated">January 2025</completion_date>
  <primary_completion_date type="Anticipated">October 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To obtain the metabolomic and proteomic fingerprint of the studied ocular surface pathologies</measure>
    <time_frame>5 years</time_frame>
    <description>Raw data will be analysed with MarkerView software by Sciex to identify specific over- or under-expressed markers in these ocular pathologies.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To objectify changes in metabolomic and proteomic profile associated with topical treatments taken by participants in this study</measure>
    <time_frame>5 years</time_frame>
    <description>Raw data will be analysed with the same software to identify specific changes in proteomic and/or metabolomic expression associated with the topical treatments taken by participants in this study.</description>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Dry Eye Syndrome</condition>
  <condition>Infectious Keratoconjunctivitis</condition>
  <condition>Mucous Membrane Pemphigoid</condition>
  <condition>Allergic Conjunctivitis</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Healthy, normal ocular surface</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dry eye syndrome</arm_group_label>
    <description>Patients suffering from either:
Lacrimal insufficiency
Anterior blepharitis
Posterior blepharitis
Sjögren syndrome</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Allergic conjunctivitis</arm_group_label>
    <description>Patients suffering from allergic conjunctivitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mucous membrane pemphigoid</arm_group_label>
    <description>Patients suffering from mucous membrane pemphigoid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Infectious keratoconjunctivitis</arm_group_label>
    <description>Patients suffering from keratitis and/or conjunctivitis of various etiology:
Viral
Bacterial
Fungal
Acanthamoeba</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Tear sample collection via Schirmer strip and subsequent analysis by mass spectrometry</intervention_name>
    <description>During regular consultations at the ophthalmology department of the CHUM, eligible patients will undergo a standard 5 minute Schirmer tear test. The Schirmer strips will serve as tear samples and will be sent to UQAM's Department of chemistry for mass spectrometry analysis.</description>
    <arm_group_label>Allergic conjunctivitis</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Dry eye syndrome</arm_group_label>
    <arm_group_label>Infectious keratoconjunctivitis</arm_group_label>
    <arm_group_label>Mucous membrane pemphigoid</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients consulting at the cornea service of the ophthalmology department of the CHUM.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with healthy corneas or suffering from one of these pathologies:

        Dry eye syndrome; Infectious keratitis and/or conjunctivitis; Mucous membrane pemphigoid;
        Allergic conjunctivitis.

        Exclusion Criteria:

          -  Patients younger than 18 years old;

          -  Patients incapable of giving informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Claude Robert, MD, M.Sc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre hospitalier de l'Université de Montréal (CHUM)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marie-Claude Robert, MD, M.Sc</last_name>
    <phone>514-890-8278</phone>
    <email>marie-claude.robert.2@umontreal.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie-Catherine Tessier</last_name>
    <phone>514-890-8000</phone>
    <phone_ext>11550</phone_ext>
    <email>marie-catherine.tessier.chum@ssss.gouv.qc.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Université du Québec à Montréal (UQAM) - Department of Chemistry</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2X 2J6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de l'Université de Montréal (CHUM)</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2X 3E4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Claude Robert, MD, M.Sc</last_name>
      <phone>514-890-8278</phone>
      <email>marie-claude.robert.2@umontreal.ca</email>
    </contact>
    <contact_backup>
      <last_name>Marie-Catherine Tessier</last_name>
      <phone>514-890-8000</phone>
      <phone_ext>11550</phone_ext>
      <email>marie-catherine.tessier.chum@ssss.gouv.qc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Marie-Claude Robert, MD, M.Sc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simon Trottier</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Karring H, Thøgersen IB, Klintworth GK, Møller-Pedersen T, Enghild JJ. A dataset of human cornea proteins identified by Peptide mass fingerprinting and tandem mass spectrometry. Mol Cell Proteomics. 2005 Sep;4(9):1406-8. Epub 2005 May 23.</citation>
    <PMID>15911533</PMID>
  </reference>
  <reference>
    <citation>Elsobky S, Crane AM, Margolis M, Carreon TA, Bhattacharya SK. Review of application of mass spectrometry for analyses of anterior eye proteome. World J Biol Chem. 2014 May 26;5(2):106-14. doi: 10.4331/wjbc.v5.i2.106. Review.</citation>
    <PMID>24921002</PMID>
  </reference>
  <reference>
    <citation>Zhou L, Zhao SZ, Koh SK, Chen L, Vaz C, Tanavde V, Li XR, Beuerman RW. In-depth analysis of the human tear proteome. J Proteomics. 2012 Jul 16;75(13):3877-85. doi: 10.1016/j.jprot.2012.04.053. Epub 2012 May 23.</citation>
    <PMID>22634083</PMID>
  </reference>
  <reference>
    <citation>Karnati R, Laurie DE, Laurie GW. Lacritin and the tear proteome as natural replacement therapy for dry eye. Exp Eye Res. 2013 Dec;117:39-52. doi: 10.1016/j.exer.2013.05.020. Epub 2013 Jun 12. Review.</citation>
    <PMID>23769845</PMID>
  </reference>
  <reference>
    <citation>de Souza GA, Godoy LM, Mann M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol. 2006;7(8):R72. Epub 2006 Aug 10.</citation>
    <PMID>16901338</PMID>
  </reference>
  <reference>
    <citation>Hagan S, Martin E, Enríquez-de-Salamanca A. Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine. EPMA J. 2016 Jul 13;7:15. doi: 10.1186/s13167-016-0065-3. eCollection 2016. Review.</citation>
    <PMID>27413414</PMID>
  </reference>
  <reference>
    <citation>Willcox MDP, Argüeso P, Georgiev GA, Holopainen JM, Laurie GW, Millar TJ, Papas EB, Rolland JP, Schmidt TA, Stahl U, Suarez T, Subbaraman LN, Uçakhan OÖ, Jones L. TFOS DEWS II Tear Film Report. Ocul Surf. 2017 Jul;15(3):366-403. doi: 10.1016/j.jtos.2017.03.006. Epub 2017 Jul 20. Review.</citation>
    <PMID>28736338</PMID>
  </reference>
  <reference>
    <citation>Aluru SV, Agarwal S, Srinivasan B, Iyer GK, Rajappa SM, Tatu U, Padmanabhan P, Subramanian N, Narayanasamy A. Lacrimal proline rich 4 (LPRR4) protein in the tear fluid is a potential biomarker of dry eye syndrome. PLoS One. 2012;7(12):e51979. doi: 10.1371/journal.pone.0051979. Epub 2012 Dec 18.</citation>
    <PMID>23272196</PMID>
  </reference>
  <reference>
    <citation>Enríquez-de-Salamanca A, Castellanos E, Stern ME, Fernández I, Carreño E, García-Vázquez C, Herreras JM, Calonge M. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010 May 19;16:862-73.</citation>
    <PMID>20508732</PMID>
  </reference>
  <reference>
    <citation>Green-Church KB, Nichols KK, Kleinholz NM, Zhang L, Nichols JJ. Investigation of the human tear film proteome using multiple proteomic approaches. Mol Vis. 2008 Mar 7;14:456-70.</citation>
    <PMID>18334958</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>December 9, 2019</study_first_submitted>
  <study_first_submitted_qc>December 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2019</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lacrimal fingerprint</keyword>
  <keyword>Metabolomics</keyword>
  <keyword>Proteomics</keyword>
  <keyword>Ocular surface</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis, Infectious</mesh_term>
    <mesh_term>Conjunctivitis</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Conjunctivitis, Allergic</mesh_term>
    <mesh_term>Keratoconjunctivitis</mesh_term>
    <mesh_term>Pemphigoid, Benign Mucous Membrane</mesh_term>
    <mesh_term>Pemphigoid, Bullous</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The investigators do not plan to share individual participant data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

